Drug
sparsentan
Marketed as FILSPARI.
Generic name
sparsentan
Brand names
FILSPARI
First FDA approval
2023-02-17
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA216403 | FILSPARI | 2023-02-17 | TRAVERE |
Manufacturers
TRAVERE
Frequently asked questions
When was sparsentan FDA approved?
Earliest FDA approval on record: 2023-02-17.
What brand names are sold as sparsentan?
FILSPARI.
Sources
Appeal a sparsentan denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com